Why Does ATAGI Recommend C0V-19 mRNA Injections for All Children Aged 5 to 11 Years?
By Elizabeth Hart
For the attention of:
– Chair of the Australian Technical Advisory Group on Immunisation (ATAGI)
– Executive Working Group Lead and Chair, Vaccine Safety, special risk groups, ATAGI COVID-19 Working Group
– Director of SAEFVIC (Surveillance of Adverse Events Following Vaccination in the Community), Murdoch Children’s Research Institute
– Medical Head, Immunisation Services, Department of General Medicine, The Royal Children’s Hospital
– Senior Fellow, Department of Paediatrics, University of Melbourne
– Member of the Expert Advisory Group, Indo-Pacific Centre for Health Security
People influential on taxpayer-funded public health/vaccination policy in Australia via:
ATAGI, the PBAC, TGA, TGA Advisory Committee on Vaccines, COVID-19 Vaccines and Treatments for Australia-Science and Industry Technical Advisory Group, NCIRS, Murdoch Children’s Research Institute, Doherty Institute, Burnet Institute, Grattan Institute, Kids Telethon Institute, Kirby Institute, Immunisation Coalition, Australian Academy of Science, NHMRC, The Conversation, university/research sector, the media, etc…
Nigel Crawford, why does ATAGI recommend the use of the paediatric Pfizer COVID-19 injection in all children aged 5 to 11 years in Australia?
ATAGI advice notes “Most children with SARS-CoV-2 infection are asymptomatic or experience a mild illness. Those who are symptomatic typically have a short illness with a median duration of 5 days…” ATAGI also notes that “…children aged 5-11 years…were the least likely of all age groups to require hospitalisation or ICU admission for COVID-19…” ATAGI also notes: “Deaths in children due to COVID-19 are rare. Data from the United Kingdom suggest that 2 per every 1 million children infected with the virus died of COVID-19.”
ATAGI advice indicates most children have an effective natural immune response to SARS-CoV-2 and are at low risk of disease, i.e. COVID-19.
Q.1. What is the independent and objective scientific evidence underpinning ATAGI’s recommendation that children aged 5 to 11 years have two injections of the TGA provisionally approved Pfizer COVID-19 COMIRNATY mRNA pharmaceutical product?
Q.2. Does the paediatric Pfizer COVID-19 mRNA injection for children aged 5 to 11 years prevent infection and transmission of SARS-CoV-2?
Q.3. What are the long term risks of initiating COVID-19 novel mRNA injections in children, such as the Pfizer COVID-19 mRNA injection?
Q.4 What impact will this medical intervention have on children’s natural immune response to SARSCoV-2 going forward?
Q.5 Is it planned to give children regular COVID-19 injections in future, as appears to be being set up across the broader population, with the securing of 280 million doses of COVID-19 injections to support the COVID-19 injection roll-out for Australia’s population of 26 million, i.e. more than 10 doses for everyone in Australia?
Q.6 What is the scientific rationale for giving COVID-19 mRNA injections to individuals at low risk from COVID-19?
Q.7 Where is the independent and objective scientific evidence demonstrating the safety of novel mRNA injections for children?
Health care practitioners are administering the Pfizer COVID-19 mRNA injections to children:
Q.8. Have any health care practitioners questioned why ATAGI recommends these COVID-19 mRNA injections for children given children’s low risk of COVID-19?
Young children are relying on their parents/carers to provide ‘valid voluntary consent’ to the COVID-19 mRNA injections on their behalf. Parents must be properly informed of the risks of ‘the virus’/disease relevant to age and health status:
Nigel Crawford, I request your early response to my questions.
Independent researcher investigating the gross over-use of vaccine products and conflicts of interest in vaccination policy